TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07098195: An OPen-label, Multicentre, Single Arm, Clinical InvestigatIon to Evaluate PerFormance and Safety of RIsoR Crest EveRolimus Eluting Coronary Stent System

Sponsor: Poly Medicure Limited · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 2000 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07098195 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07098195 Rescue Dossier →